Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)

ClinicalTrials.gov ID: NCT02289846

Public ClinicalTrials.gov record NCT02289846. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 5:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Phase 2a Study of Oral IW-9179 Administered Once and Twice Daily for 4 Weeks to Patients With Diabetic Gastroparesis

Study identification

NCT ID
NCT02289846
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ironwood Pharmaceuticals, Inc.
Industry
Enrollment
90 participants

Conditions and interventions

Interventions

  • IW-9179 Drug
  • Matching Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2014
Primary completion
Nov 30, 2015
Completion
Nov 30, 2015
Last update posted
Dec 4, 2016

2014 – 2015

United States locations

U.S. sites
22
U.S. states
14
U.S. cities
22
Facility City State ZIP Site status
Ironwood Investigational Site Birmingham Alabama 35203
Ironwood Investigational Site Dothan Alabama 36305
Ironwood Investigational Site Tucson Arizona 85710
Ironwood Investigational Site North Little Rock Arkansas 72117
Ironwood Investigational Site Chula Vista California 91910
Ironwood Investigational Site Los Angeles California 90036
Ironwood Investigational Site Ventura California 93003
Ironwood Investigational Site Miami Florida 33122
Ironwood Investigational Site Tampa Florida 33607
Ironwood Investigational Site Urbana Illinois 61801
Ironwood Investigational Site Bastrop Louisiana 71220
Ironwood Investigational Site Chesterfield Michigan 48047
Ironwood Investigational Site Rochester Minnesota 55905
Ironwood Investigational Site Great Neck New York 11023
Ironwood Investigational Site New York New York 10018
Ironwood Investigational Site Poughkeepsie New York 12601
Ironwood Investigational Site Greensboro North Carolina 27410
Ironwood Investigational Site Winston-Salem North Carolina 27103
Ironwood Investigational Site Chattanooga Tennessee 37421
Ironwood Investigational Site Houston Texas 77015
Ironwood Investigational Site Webster Texas 77598
Ironwood Investigational Site Ogden Utah 84405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02289846, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 4, 2016 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02289846 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →